Difference between revisions of "Toremifene (Fareston)"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m
Line 14: Line 14:
 
*[http://chemocare.com/bio/toremifene.asp Toremifene (Fareston) patient drug information (Chemocare)]<ref>[http://chemocare.com/bio/toremifene.asp Toremifene (Fareston) patient drug information (Chemocare)]</ref>
 
*[http://chemocare.com/bio/toremifene.asp Toremifene (Fareston) patient drug information (Chemocare)]<ref>[http://chemocare.com/bio/toremifene.asp Toremifene (Fareston) patient drug information (Chemocare)]</ref>
 
*[http://www.uptodate.com/contents/toremifene-patient-drug-information Toremifene (Fareston) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/toremifene-patient-drug-information Toremifene (Fareston) patient drug information (UpToDate)]</ref>
 
*[http://www.uptodate.com/contents/toremifene-patient-drug-information Toremifene (Fareston) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/toremifene-patient-drug-information Toremifene (Fareston) patient drug information (UpToDate)]</ref>
 +
 +
==History of changes in FDA indication==
 +
* 5/29/1997: Initial FDA approval
  
 
==References==
 
==References==
 
<references/>
 
<references/>
 +
 +
[[Category:Drug index]]
 +
[[Category:Endocrine therapy]]
 +
[[Category:Selective estrogen receptor modulators]]
 +
 +
[[Category:Breast cancer medications]]
 +
 +
[[Category:Drugs FDA approved in 1997]]

Revision as of 02:33, 3 November 2014

Also known as Acapodene.

General information

Class/mechanism: SERM (selective estrogen receptor modulator), with estrogen agonist/antagonist properties depending on tissue type.[1][2][3]
Route: PO
Extravasation: n/a

For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]

Diseases for which it is used

Patient drug information

History of changes in FDA indication

  • 5/29/1997: Initial FDA approval

References